PortfoliosLab logoPortfoliosLab logo
PAF.L vs. NVO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PAF.L vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in Pan African Resources plc (PAF.L) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

PAF.L is traded in GBp, while NVO is traded in USD. To make them comparable, the NVO values have been converted to GBp using the latest available exchange rates.

Returns By Period

In the year-to-date period, PAF.L achieves a -9.60% return, which is significantly higher than NVO's -10.29% return. Over the past 10 years, PAF.L has outperformed NVO with an annualized return of 24.42%, while NVO has yielded a comparatively lower 8.12% annualized return.


PAF.L

1D
5.62%
1M
-26.94%
YTD
-9.60%
6M
-1.63%
1Y
129.47%
3Y*
108.56%
5Y*
46.75%
10Y*
24.42%

NVO

1D
-0.09%
1M
-5.98%
YTD
-10.29%
6M
-9.72%
1Y
-42.44%
3Y*
-17.29%
5Y*
3.99%
10Y*
8.12%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PAF.L vs. NVO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
PAF.L
Pan African Resources plc
-9.60%258.03%109.32%6.38%4.14%-25.77%102.96%40.81%-34.94%-11.75%
NVO
Novo Nordisk A/S
-10.29%-43.55%-14.46%47.10%37.24%65.07%19.71%23.81%-7.82%39.70%

Correlation

The correlation between PAF.L and NVO is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.11

Correlation (3Y)
Calculated over the trailing 3-year period

0.08

Correlation (5Y)
Calculated over the trailing 5-year period

0.02

Correlation (10Y)
Calculated over the trailing 10-year period

0.06

Correlation (All Time)
Calculated using the full available price history since Jul 11, 2007

0.05

Fundamentals

Market Cap

PAF.L:

£2.21B

NVO:

$195.21B

EPS

PAF.L:

$0.29

NVO:

DKK 27.42

PE Ratio

PAF.L:

4.95

NVO:

10.34

PEG Ratio

PAF.L:

0.01

NVO:

0.44

PS Ratio

PAF.L:

1.51

NVO:

3.85

PB Ratio

PAF.L:

4.29

NVO:

6.21

Total Revenue (TTM)

PAF.L:

$1.03B

NVO:

DKK 327.80B

Gross Profit (TTM)

PAF.L:

$489.97M

NVO:

DKK 268.30B

EBITDA (TTM)

PAF.L:

$528.52M

NVO:

DKK 181.54B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PAF.L vs. NVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PAF.L
PAF.L Risk / Return Rank: 8888
Overall Rank
PAF.L Sharpe Ratio Rank: 9393
Sharpe Ratio Rank
PAF.L Sortino Ratio Rank: 8787
Sortino Ratio Rank
PAF.L Omega Ratio Rank: 8787
Omega Ratio Rank
PAF.L Calmar Ratio Rank: 8484
Calmar Ratio Rank
PAF.L Martin Ratio Rank: 8888
Martin Ratio Rank

NVO
NVO Risk / Return Rank: 1212
Overall Rank
NVO Sharpe Ratio Rank: 99
Sharpe Ratio Rank
NVO Sortino Ratio Rank: 1212
Sortino Ratio Rank
NVO Omega Ratio Rank: 1010
Omega Ratio Rank
NVO Calmar Ratio Rank: 1212
Calmar Ratio Rank
NVO Martin Ratio Rank: 1616
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PAF.L vs. NVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Pan African Resources plc (PAF.L) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


PAF.LNVODifference
Sharpe ratioReturn per unit of total volatility

+3.28

Sortino ratioReturn per unit of downside risk

+3.72

Omega ratioGain probability vs. loss probability

1.36

0.85

+0.51

Calmar ratioReturn relative to maximum drawdown

2.95

-0.80

+3.75

Martin ratioReturn relative to average drawdown

9.67

-1.18

+10.85

PAF.L vs. NVO - Sharpe Ratio Comparison

The current PAF.L Sharpe Ratio is 2.44, which is higher than the NVO Sharpe Ratio of -0.84. The chart below compares the historical Sharpe Ratios of PAF.L and NVO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

PAF.L vs. NVO - Drawdown Comparison

The maximum PAF.L drawdown since its inception was -80.73%, which is greater than NVO's maximum drawdown of -75.79%. Use the drawdown chart below to compare losses from any high point for PAF.L and NVO.


Loading charts...

Drawdown Indicators


PAF.LNVODifference

Max Drawdown

Largest peak-to-trough decline

-80.73%

-75.79%

-4.94%

Max Drawdown (1Y)

Largest decline over 1 year

-44.73%

-53.28%

+8.55%

Max Drawdown (3Y)

Largest decline over 3 years

-44.73%

-75.79%

+31.06%

Max Drawdown (5Y)

Largest decline over 5 years

-47.34%

-75.79%

+28.45%

Max Drawdown (10Y)

Largest decline over 10 years

-70.68%

-75.79%

+5.11%

Current Drawdown

Current decline from peak

-40.36%

-69.82%

+29.46%

Average Drawdown

Average peak-to-trough decline

-29.27%

-11.97%

-17.30%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.65%

36.79%

-23.14%

Volatility

PAF.L vs. NVO - Volatility Comparison

Pan African Resources plc (PAF.L) has a higher volatility of 21.97% compared to Novo Nordisk A/S (NVO) at 10.14%. This indicates that PAF.L's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PAF.LNVODifference

Volatility (1M)

Calculated over the trailing 1-month period

21.97%

10.14%

+11.83%

Volatility (6M)

Calculated over the trailing 6-month period

44.78%

37.12%

+7.66%

Volatility (1Y)

Calculated over the trailing 1-year period

54.10%

50.71%

+3.39%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

48.00%

37.92%

+10.08%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

53.54%

32.66%

+20.88%

Dividends

PAF.L vs. NVO - Dividend Comparison

PAF.L's dividend yield for the trailing twelve months is around 2.00%, less than NVO's 4.11% yield.


PositionTTM20252024202320222021202020192018201720162015
NVO
Novo Nordisk A/S
4.11%3.31%1.68%1.00%1.20%1.35%1.87%2.14%1.45%1.52%2.87%0.92%
PAF.L
Pan African Resources plc
2.00%1.35%2.79%4.52%5.25%5.09%2.92%0.98%0.00%3.38%5.67%6.83%

Financials

PAF.L vs. NVO - Financials Comparison

This section allows you to compare key financial metrics between Pan African Resources plc and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B100.00B202120222023202420252026
489.40M
96.82B
(PAF.L) Total Revenue
(NVO) Total Revenue
Please note, different currencies. PAF.L values in USD, NVO values in DKK

PAF.L vs. NVO - Profitability Comparison

The chart below illustrates the profitability comparison between Pan African Resources plc and Novo Nordisk A/S over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%80.0%90.0%202120222023202420252026
54.1%
86.0%
Portfolio components
PAF.L - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Pan African Resources plc reported a gross profit of 264.90M and revenue of 489.40M. Therefore, the gross margin over that period was 54.1%.

NVO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.

PAF.L - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Pan African Resources plc reported an operating income of 257.33M and revenue of 489.40M, resulting in an operating margin of 52.6%.

NVO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.

PAF.L - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Pan African Resources plc reported a net income of 148.68M and revenue of 489.40M, resulting in a net margin of 30.4%.

NVO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.


Frequently Asked Questions


PAF.L and NVO have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for PAF.L and NVO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer